Other Income/Expenses (Net)

$10.47M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$10.47Mperiod endingJun 30, 2026

LCTX Quarterly Other Income/Expenses (Net) ($0.00 → $10.47M)

Quarterly Other Income/Expenses (Net)

High-resolution chart · PNG

LCTX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Other Income/Expenses (Net) — Quarterly (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	0
Sep 30, 2000	0
Jun 30, 2000	0
Mar 31, 2000	0
Dec 31, 1999	0
Sep 30, 1999	2,400,000
Jun 30, 1999	0
Mar 31, 1999	800,000
Sep 30, 1998	100,000
Jun 30, 1998	100,000
Mar 31, 1998	100,000
Dec 31, 1997	100,000
Sep 30, 1997	100,000
Jun 30, 1997	100,000
Mar 31, 1997	500,000
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	2,100,000
Mar 31, 1996	-100,000
Dec 31, 1995	-100,000
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	100,000
Sep 30, 1994	100,000
Jun 30, 1994	100,000
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	300,000
Jun 30, 1993	0
Mar 31, 1993	200,000
Dec 31, 1992	300,000
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0